Bupi Yishen formula attenuates kidney injury in 5/6 nephrectomized rats via the tryptophan-kynurenic acid-aryl hydrocarbon receptor pathway

Bupi Yishen Formula (BYF), a patent traditional Chinese medicine (TCM) formulation, has been used in the clinical treatment of chronic kidney disease (CKD). However, the mechanism of action of BYF has not been...

Source: BMC Complementary and Alternative Medicine - August 10, 2021 Category: Complementary Medicine Authors: Yenan Mo, Xina Jie, Lixin Wang, Chunlan Ji, Yueyu Gu, Zhaoyu Lu and Xusheng Liu Tags: Research article Source Type: research